Effect of Codonopsis Radix and Polygonati Rhizoma on the regulation of the IRS1/PI3K/AKT signaling pathway in type 2 diabetic mice.
Codonopsis Radix and Polygonati Rhizoma
hypoglycemic
pathology section
type 2 diabetes mellitus
western blotting
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
10
2022
accepted:
01
12
2022
entrez:
2
1
2023
pubmed:
3
1
2023
medline:
4
1
2023
Statut:
epublish
Résumé
Codonopsis Radix and Polygonati Rhizoma (CRPR) has a good hypoglycemic effect. The aims of the present study were to investigate the effect of CRPR on high-fat/high-sugar diet (HFHSD)- and streptozotocin (STZ)-induced type 2 diabetes mellitus (T2DM) mice as well as to investigate the involved mechanism. A T2DM mouse model was generated by combining HFHSD and STZ. After the model was established, normal and model groups received the same volume of normal saline intragastrically, and the negative control group was treated with metformin (200 mg/kg·BW). The low, medium, and high CRPR groups received four consecutive weeks of oral gavage with CRPR doses of 2.5, 5, and 10 g/kg·BW, respectively, during the course of the study. Body weight and fasting blood glucose (FBG) were measured on a weekly basis. Enzyme-linked immunosorbent assay (ELISAs) were used to evaluate the serum and liver samples. Hematoxylin and eosin (H&E) staining was utilized to observe the pathological status of the liver and pancreas. Western blot (WB) analysis was performed to evaluate the protein expression levels of PI3K, p-PI3K, AKT, and p-AKT. Compared to model mice, each treatment group had significantly elevated levels of FBG, total cholesterol (TC), and triacylglycerol (TG) ( The present study demonstrated that CRPR effectively improves the metabolic disturbance of lipids, repairs damaged liver tissues, repairs damaged pancreatic tissues, and reduces insulin resistance (IR) in T2DM mice. The mechanism of action may be associated with upregulation of the IRS1/PI3K/AKT signaling pathway and inhibition of IRS1 phosphorylation.
Identifiants
pubmed: 36589810
doi: 10.3389/fendo.2022.1068555
pmc: PMC9794842
doi:
Substances chimiques
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Phosphatidylinositol 3-Kinases
EC 2.7.1.-
Blood Glucose
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1068555Informations de copyright
Copyright © 2022 Mao, Song, Pan, Li, Wang, Feng and Zhang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Chem Biol Interact. 2021 Apr 1;338:109427
pubmed: 33639173
Front Pharmacol. 2022 Sep 02;13:960050
pubmed: 36120310
BMJ. 2020 Apr 28;369:m997
pubmed: 32345662
Mol Genet Metab. 2016 Nov;119(3):288-292
pubmed: 27746033
Trends Genet. 2020 Jun;36(6):429-441
pubmed: 32396836
Biomed Pharmacother. 2018 Oct;106:733-737
pubmed: 29990865
Biomed Pharmacother. 2021 Nov;143:112155
pubmed: 34517283
Diabetes Metab Syndr Obes. 2020 Mar 17;13:739-751
pubmed: 32231437
Phytochemistry. 2022 Sep;201:113286
pubmed: 35752344
Food Chem Toxicol. 2017 Oct;108(Pt B):498-509
pubmed: 28087233
Biomed Pharmacother. 2020 Nov;131:110687
pubmed: 33152904
Antioxidants (Basel). 2022 Aug 30;11(9):
pubmed: 36139776
Nutrients. 2017 Nov 01;9(11):
pubmed: 29104217
J Agric Food Chem. 2021 Mar 3;69(8):2444-2456
pubmed: 33605141
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Diabetol Metab Syndr. 2022 Sep 20;14(1):135
pubmed: 36127704
Front Nutr. 2022 Apr 15;9:854725
pubmed: 35495933
Pharmacol Res. 2020 Jul;157:104831
pubmed: 32339782
J Mol Endocrinol. 2018 Jan;60(1):R1-R8
pubmed: 29093014
Aging (Albany NY). 2018 May 20;10(5):1027-1052
pubmed: 29779018
J Agric Food Chem. 2019 May 8;67(18):5278-5288
pubmed: 30964673
Carbohydr Polym. 2018 Oct 1;197:215-226
pubmed: 30007607
Front Pharmacol. 2018 Jan 26;9:10
pubmed: 29434546
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Oct;1863(10):1274-1284
pubmed: 30305244
Biomass Convers Biorefin. 2022 Mar 19;:1-17
pubmed: 35342681
Arch Biochem Biophys. 2016 Jun 1;599:13-21
pubmed: 26968772
Zhongguo Zhong Yao Za Zhi. 2022 May;47(10):2705-2711
pubmed: 35718490
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221137435
pubmed: 36319192